Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02322307 · ClinicalTrials.gov registry record · NA

Trial on Impact of HealthPROMISE Mobile App on Inflammatory Bowel Disease Care and Quality of Life

A NA study of Ulcerative Colitis and Crohn's Disease, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
320
Enrollment target
1
Study location

NCT02322307 is a NA study of Ulcerative Colitis and Crohn's Disease that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 320 participants, below the 2,055-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02322307, a NA study of Ulcerative Colitis and Crohn's Disease, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
320 participants
Enrollment target
1
Study location

Study Summary

HealthPROMISE is a mobile application (app) for patients that allows regular tracking of symptoms by patients and communicates them to physicians. The purpose of this randomized controlled trial is to determine the impact of the HealthPROMISE application on improving patient outcomes. The trial will look at how much patients use the application, whether physicians change treatment in response to new information from patients, and how the patients quality of life change over the span of the study. The investigators hypothesize that HealthPROMISE will enhance physician-patient communication and improve clinical outcomes.

Conditions Studied

Ulcerative Colitis Crohn's Disease Inflammatory Bowel Disease

Interventions

  • OTHER Control Group
  • OTHER HealthPROMISE users

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 320 participants
Start Date 2015-02
Est. Completion 2020-01-20
Phase NA

Sponsor

Icahn School of Medicine at Mount Sinai

708 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02322307

The ClinicalTrials.gov registry entry for NCT02322307 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,055-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (84% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Ulcerative Colitis appearing as the primary indexed condition, and to 2 interventions - of which Control Group is the first listed.

NCT02322307 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02322307 about?

NCT02322307 is a clinical study titled "Trial on Impact of HealthPROMISE Mobile App on Inflammatory Bowel Disease Care and Quality of Life". HealthPROMISE is a mobile application (app) for patients that allows regular tracking of symptoms by patients and communicates them to physicians. The purpose of this randomized controlled trial is to determine the impact of the HealthPROMISE application on improving patient outcomes. The trial will...

What is the current status of trial NCT02322307?

This trial is currently completed. It is a NA study. The enrollment target is 320 participants. The study started on 2015-02. Estimated completion is 2020-01-20.

What conditions does trial NCT02322307 study?

This clinical trial studies the following conditions: Ulcerative Colitis, Crohn's Disease, Inflammatory Bowel Disease.

What interventions are being tested in trial NCT02322307?

The interventions under investigation include: Control Group (OTHER), HealthPROMISE users (OTHER).

Who is sponsoring clinical trial NCT02322307?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02322307 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ulcerative Colitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ulcerative Colitis

All registered trials for this condition

Crohn's Disease

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.